Grantham, Mayo, Van Otterloo & Co (GMO)’s Equinor EQNR Stock Holding History
Bought
Maintained
Sold
Other funds holding EQNR
F
Grantham, Mayo, Van Otterloo & Co (GMO)'s EQNR Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Equinor (EQNR) stake by 26% in Q2 2026, selling an estimated $3.19M and leaving 249,188 shares worth $7.82M. The position accounts for 0.02% of the portfolio, ranked #277.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EQNR in Q1 2016 and has held it in 10 quarters since. The position peaked at $14.1M in Q1 2026. 412 funds tracked by Wall St. Rank hold EQNR as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 249,188 shares of Equinor worth $7.82M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 85,352 Equinor shares in Q2 2026, an estimated $3.19M.
- Equinor made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #277 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Equinor in Q1 2016 and has held it in 10 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Equinor position peaked at $14.1M in Q1 2026.
- 412 funds tracked by Wall St. Rank held Equinor as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.